Loading…
Cell and Gene Therapy Catapult is a UK organization that accelerates the development and commercialization of advanced therapy medicinal products (ATMPs) by providing specialized infrastructure, expertise, and collaboration across the cell and gene therapy lifecycle. It supports industry growth, manufacturing innovation, and NHS adoption while tracking measurable impacts like increased clinical trials and sector investment.
AI named CGT Catapult in November 2025.